In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675

With the recent introduction of neuraminidase (NA) inhibitors into clinical practice for the treatment of influenza virus infections, considerable attention has been focused on the potential for resistance development and cross-resistance between different agents from this class. A-315675 is a novel...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Molla, Akhteruzzaman, Kati, Warren, Carrick, Robert, Steffy, Kevin, Shi, Yan, Montgomery, Debra, Gusick, Nanette, Stoll, Vincent S., Stewart, Kent D., Ng, Teresa I., Maring, Clarence, Kempf, Dale J., Kohlbrenner, William
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC137025/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11991966/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.11.5380-5386.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!